Mariângela Moreno Domingues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mariângela Moreno Domingues has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
A. Ayako Kamogari de Araújo
Federal University Of Pará, Postgraduate program in Tropical Diseases, Belem, Brazil
1 shared publication- Akim Felipe Santos Nobre
Universidade federal do Pará
1 shared publication - Alna Carolina Mendes Paranhos
Universidade do Estado do Pará, Belém, Brazil
1 shared publication - Antonio Carlos Rosário Vallinoto
Universidade federal do Pará
1 shared publication - Apio Ricardo Nazareth Dias
Núcleo de Medicina Tropical, Universidade Federal do Pará, Belém, Brazil
1 shared publication - Barbara Brasil Santana
Universidade federal do Pará
1 shared publication
Latest Publications
- 12 September 2025
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (1) , 267-274
Persistent olfactory dysfunction as an indicator of cognitive impairment in long COVID-19 syndrome: implications for monitoring and rehabilitation
Persistent olfactory dysfunction (OD) and cognitive impairment are among the most frequently reported sequelae of long term infection with SARS-CoV-2 (long COVID-19). However, the association between these conditions remains unclear. This study investigated the correlation between OD and cognitive impairment in patients recovering from COVID-19 to identify the implications for therapeutic and rehabilitation strategies. A cross-sectional study of adult patients diagnosed with long COVID was conducted at a healthcare centre in Brazil. Olfactory function was assessed using the Connecticut Chemosensory Clinical Research Centre (CCCRC) test, and cognitive performance was evaluated using the Montreal Cognitive Assessment (MoCA). Statistical analyses included odds ratios (OR) and linear regression to explore the association between OD severity and cognitive scores, adjusting for potential confounders such as age, sex, and comorbidities. A total of 241 patients (age: 48.60 ± 12.68 years; 73% female) were included. Cognitive impairment (MoCA < 23) was present in 64% of the participants. OD was identified in 92% of the patients and ranged from mild to anosmia. Linear regression analysis showed a weak yet statistically significant correlation between the CCCRC and MoCA scores (R = 0.14, p = 0.02). An OR of 2.87 (95% CI: 1.57-5.25, p = 0.00) indicated higher odds of cognitive impairment in patients with severe OD. This study supports the hypothesis that there is a weak yet significant association between OD and cognitive impairment in patients with long COVID. These findings underscore the importance of early screening for olfactory dysfunction as a potential marker of cognitive monitoring and the need for intervention in this population.
- 12 September 2025
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 276 (1) , 267-274
Persistent olfactory dysfunction as an indicator of cognitive impairment in long COVID-19 syndrome: implications for monitoring and rehabilitation
Persistent olfactory dysfunction (OD) and cognitive impairment are among the most frequently reported sequelae of long term infection with SARS-CoV-2 (long COVID-19). However, the association between these conditions remains unclear. This study investigated the correlation between OD and cognitive impairment in patients recovering from COVID-19 to identify the implications for therapeutic and rehabilitation strategies. A cross-sectional study of adult patients diagnosed with long COVID was conducted at a healthcare centre in Brazil. Olfactory function was assessed using the Connecticut Chemosensory Clinical Research Centre (CCCRC) test, and cognitive performance was evaluated using the Montreal Cognitive Assessment (MoCA). Statistical analyses included odds ratios (OR) and linear regression to explore the association between OD severity and cognitive scores, adjusting for potential confounders such as age, sex, and comorbidities. A total of 241 patients (age: 48.60 ± 12.68 years; 73% female) were included. Cognitive impairment (MoCA < 23) was present in 64% of the participants. OD was identified in 92% of the patients and ranged from mild to anosmia. Linear regression analysis showed a weak yet statistically significant correlation between the CCCRC and MoCA scores (R = 0.14, p = 0.02). An OR of 2.87 (95% CI: 1.57-5.25, p = 0.00) indicated higher odds of cognitive impairment in patients with severe OD. This study supports the hypothesis that there is a weak yet significant association between OD and cognitive impairment in patients with long COVID. These findings underscore the importance of early screening for olfactory dysfunction as a potential marker of cognitive monitoring and the need for intervention in this population.
- Open Access
- 2 March 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (3)
Análise dos níveis de carga proviral em portadores de HTLV-1 com diferentes condições de comprometimento neurológico
Objetivos: Analisar os níveis da carga proviral (CPV) em portadores de HTLV-1 com diferentes condições de comprometimento neurológico. Metodologia: Estudo transversal, realizado de março a outubro de 2017, com 43 pacientes com HTLV-1, divididos em três grupos por ordem decrescente de envolvimento neurológico, segundo proposta atualizada dos critérios de diagnóstico clínico para HAM/TSP: Definidos para HAM/TSP (Grupo 1, n=7); Prováveis/Possíveis para HAM/TSP (Grupo 2, n=9); Sem HAM/TSP (Grupo 3, n=27). O teste ANOVA (um critério) foi utilizado para verificar a diferença entre as médias de CPV dos grupos (p-valor≤0,05). Resultados: Os grupos apresentaram os seguintes valores médios de CPV: G1=9.00±11.18; G2=1.88±3.92; G3=2.81±4.03 cópias/106 PBMC. Na comparação intergrupo, da diferença entre as médias de CPV, foi observada diferença significativa entre os grupos 1 e 2 e entre os grupos 1 e 3 (p
- 2 March 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (3)
Open AccessAnálise dos níveis de carga proviral em portadores de HTLV-1 com diferentes condições de comprometimento neurológico
Objetivos: Analisar os níveis da carga proviral (CPV) em portadores de HTLV-1 com diferentes condições de comprometimento neurológico. Metodologia: Estudo transversal, realizado de março a outubro de 2017, com 43 pacientes com HTLV-1, divididos em três grupos por ordem decrescente de envolvimento neurológico, segundo proposta atualizada dos critérios de diagnóstico clínico para HAM/TSP: Definidos para HAM/TSP (Grupo 1, n=7); Prováveis/Possíveis para HAM/TSP (Grupo 2, n=9); Sem HAM/TSP (Grupo 3, n=27). O teste ANOVA (um critério) foi utilizado para verificar a diferença entre as médias de CPV dos grupos (p-valor≤0,05). Resultados: Os grupos apresentaram os seguintes valores médios de CPV: G1=9.00±11.18; G2=1.88±3.92; G3=2.81±4.03 cópias/106 PBMC. Na comparação intergrupo, da diferença entre as médias de CPV, foi observada diferença significativa entre os grupos 1 e 2 e entre os grupos 1 e 3 (p
- Open Access
- 1 October 2019
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 405, 255-256
Somatosensory psychophysic losses in inhabitants of riverside communities of the Tapajós river basin, Amazonas, Brazil: The possible involvement of exposure to methylmercury
- 1 October 2019
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 405, 255-256
Open AccessSomatosensory psychophysic losses in inhabitants of riverside communities of the Tapajós river basin, Amazonas, Brazil: The possible involvement of exposure to methylmercury